Single Agent Armodafinil for Patient-Reported Fatigue Following Radiation Therapy for Head and Neck Cancer

NCT01330446 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Head And Neck Cancer
Fatigue

Interventions

DRUG: Armodafinil
OTHER: Placebo
BEHAVIORAL: Questionnaires

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]